Litcius/Paper detail

Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement

Gilles Montalescot, Alban Redheuil, Flavien Vincent, Steffen Desch, Mauro De Benedictis, Hélène Eltchaninoff, Dietmar Trenk, Jean‐Michel Serfaty, Etienne Charpentier, Khaoula Bouazizi, Mikael Prigent, Paul Guedeney, Tomy Salloum, Sérgio Berti, Ángel Cequier, Thierry Lefèvre, Pascal Leprince, Johanne Silvain, Éric Van Belle, Franz‐Josef Neumann, Jean-Jacques Portal, Éric Vicaut, Jean‐Philippe Collet

2022JACC: Cardiovascular Interventions68 citationsDOI

Topics & Concepts

MedicineApixabanCardiologyStroke (engine)Internal medicineValve replacementThrombosisPopulationAortic valveClinical endpointStenosisMyocardial infarctionSurgeryRandomized controlled trialAtrial fibrillationWarfarinRivaroxabanEnvironmental healthEngineeringMechanical engineeringCardiac Valve Diseases and TreatmentsAtrial Fibrillation Management and OutcomesAortic Disease and Treatment Approaches
Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement | Litcius